Skip to search.
 TSX Down0.80% TSX Ventures 0.00%

Tranzyme, Inc. (TZYM)

-NasdaqGM

0.51 Jun 19, 3:59PM EDT

Add to Portfolio
Income StatementGet Income Statement for:
View: Annual Data | Quarterly DataAll numbers in thousands
Period Ending2012-12-302011-12-302010-12-30
Total Revenue 8,447   10,167   8,538  
Cost of Revenue -   -   -  
Gross Profit 8,447   10,167   8,538  
Operating Expenses
Research Development20,980  24,884  10,081  
Selling General and Administrative6,561  6,028  3,872  
Non Recurring -   -   -  
Others -   -   -  
Total Operating Expenses -   -   -  
Operating Income or Loss (19,094) (20,745) (5,415)
Income from Continuing Operations
Total Other Income/Expenses Net(1,373)126  (392)
Earnings Before Interest And Taxes(20,467)(20,619)(5,807)
Interest Expense2,377  1,589  1,493  
Income Before Tax(22,844)(22,208)(7,300)
Income Tax Expense -   -   -  
Minority Interest -   -   -  
Net Income From Continuing Ops(22,844)(22,208)(7,300)
Non-recurring Events
Discontinued Operations -   -   -  
Extraordinary Items -   -   -  
Effect Of Accounting Changes -   -   -  
Other Items -   -   -  
Net Income (22,844) (22,208) (7,300)
Preferred Stock And Other Adjustments -   -   -  
Net Income Applicable To Common Shares (22,844) (22,208) (7,300)

Sign Up for a Free Trial to EDGAR Online Premium!
Get the critical business and financial information you need for more than 15,000 U.S. public companies.
Sign Up Now - Learn More

Currency in USD.